TPD7 inhibits the growth of cutaneous T cell lymphoma H9 cell through regulating IL‐2R signalling pathway

IL‐2R pathway is a key regulator in the development of immune cells and has emerged as a promising drug target in cancer treatment, but there is a scarcity of related inhibitors. TPD7 is a novel biphenyl urea taspine derivate, which has been shown anti‐cancer effect. Here, we demonstrated the anti‐c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Man, Yang, Liu, Shi, Xianpeng, Gong, Zhengyan, Yu, Runze, Zhang, Dongdong, Zhang, Yanmin, Ma, Weina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933353/
https://www.ncbi.nlm.nih.gov/pubmed/31742861
http://dx.doi.org/10.1111/jcmm.14810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933353/
https://www.ncbi.nlm.nih.gov/pubmed/31742861
http://dx.doi.org/10.1111/jcmm.14810

Ejemplares similares